The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms

American Journal of Gastroenterology

Volumn 99, Issue 12, 2004, Pages 2452-2458

  Rosen, Rachel ^a   Nurko, Samuel ^a  

^a Dept of Gastroenterol and Nutr ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; APNEA; ASTHMA; BREATH HOLDING; CHILD; CHRONIC LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; ESOPHAGITIS; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IMPEDANCE; INFANT; LOGISTIC REGRESSION ANALYSIS; MALE; MULTICHANNEL RECORDER; MULTIVARIATE ANALYSIS; OXYGEN SATURATION; PH MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; REVIEW; STRIDOR; SYMPTOM; TACHYPNEA; WHEEZING;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ELECTRIC IMPEDANCE; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; MALE; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 11144282402     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40268.x     Document Type: Review

References (36)

1. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32:S1-31.
2. Lazenby JP, Harding SM. Chronic cough, asthma, and gastroesophageal reflux. Curr Gastroenterol Rep 2000;2:217-23.
3. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: Respiratory symptom correlation with esophageal acid events. Chest 1999;115:654-9.
4. Harding SM. Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med 2001;111(suppl 8A):8S-12S.
5. Bilgen C, Ogut F, Kesimli-Dinc H, et al. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux. J Laryngol Otol 2003;117:386-90.
6. O'Connor JB, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: A review. Am J Gastroenterol 2000;95:3356-64.
7. Gustafsson PM, Kjellman NI, Tibbling L. A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux. Eur Respir J 1992;5:201-6.
8. Kiljander TO, Salomaa ER, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999;116:1257-64.
9. Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994;39:2127-33.
10. Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: An evaluation based on clinical practice. Dig Dis Sci 2003;48:2117-23.
11. Bowrey DJ, Peters JH, DeMeester TR. Gastroesophageal reflux disease in asthma: Effects of medical and surgical antireflux therapy on asthma control. Ann Surg 2000;231:161-72.
12. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome. Am J Med 1996;100:395-405.
13. Sifrim D, Holloway R, Silny J, et al. Composition of the post-prandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96:647-55.
14. Wenzl TG, Silny J, Schenke S, et al. Gastroesophageal reflux and respiratory phenomena in infants: Status of the intraluminal impedance technique. J Pediatr Gastroenterol Nutr 1999;28:423-8.
15. Texter EC, Jr. A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound. Am J Gastroenterol 1989;84:97-108.
16. Gillen D, McColl KE. Problems related to acid rebound and tachyphylaxis. Best Pract Res Clin Gastroenterol 2001;15:487-95.
17. Vela MF, Tutuian R, Sifrim D, et al. Comparison of pH-metry versus combined multichannel intraluminal impedance and pH (MII-pH) for symptom association sudies in symptomatic, acid supressed GERD patients. Gastroenterology 2003;124:A542.0000
18. Singh S, Richter JE, Bradley LA, et al. The Symptom Index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993;38:1402-8.
19. Breumelhof R, Smout AJ. The symptom sensitivity index: A valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991;86:160-4.
20. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
21. Katzka DA, Paoletti V, Leite L, et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;91:2110-3.
22. Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001;280:G457-62.
23. Lam HG, Breumelhof R, Roelofs JM, et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 1994;39:402-9.
24. Chitkara DK, Fortunato C, Nurko S. Prolonged monitoring of esophageal motor function in healthy children. J Pediatr Gastroenterol Nutr 2004;38:192-7.
25. Tomonaga T, Awad ZT, Filipi CJ, et al. Symptom predictability of reflux-induced respiratory disease. Dig Dis Sci 2002;47:9-14.
26. Wunderlich AW, Murray JA. Temporal correlation between chronic cough and gastroesophageal reflux disease. Dig Dis Sci 2003;48:1050-6.
27. Cucchiara S, Campanozzi A, Greco L, et al. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children. Am J Gastroenterol 1996;91:680-5.
28. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 2002;112:1861-5.
29. Shirvani VN, Ouatu-Lascar R, Kaur BS, et al. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-96.
30. Sung MW, Roh JL, Park BJ, et al. Bile acid induces cyclooxygenase-2 expression in cultured human pharyngeal cells: A possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 2003;113:1059-63.
31. Orel R, Markovic S. Bile in the esophagus: A factor in the pathogenesis of reflux esophagitis in children. J Pediatr Gastroenterol Nutr 2003;36:266-73.
32. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-9.
33. Oliven A, Haxhiu M, Kelsen SG. Reflex effect of esophageal distension on respiratory muscle activity and pressure. J Appl Physiol 1989;66:536-41.
34. Davis RS, Larsen GL, Grunstein MM. Respiratory response to intraesophageal acid infusion in asthmatic children during sleep. J Allergy Clin Immunol 1983;72:393-8.
35. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole. Gastroenterology 2001;120:1599-606.
36. Vela MF, Tutuian R, Katz PO, et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003;17:243-51.